LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 8.576
EU - Europa 5.384
AS - Asia 1.273
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 4
OC - Oceania 3
Totale 15.265
Nazione #
US - Stati Uniti d'America 8.559
UA - Ucraina 1.389
SE - Svezia 835
IE - Irlanda 708
IT - Italia 691
TR - Turchia 644
DE - Germania 630
DK - Danimarca 537
FI - Finlandia 310
KR - Corea 286
SG - Singapore 242
GB - Regno Unito 181
CN - Cina 58
FR - Francia 47
IN - India 33
BE - Belgio 27
EU - Europa 25
CA - Canada 14
RU - Federazione Russa 11
HK - Hong Kong 5
BR - Brasile 4
ES - Italia 4
GR - Grecia 4
BZ - Belize 3
CH - Svizzera 3
AU - Australia 2
HR - Croazia 2
NL - Olanda 2
TH - Thailandia 2
BG - Bulgaria 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 15.265
Città #
Jacksonville 1.424
Chandler 1.056
Fairfield 784
Dublin 706
Wilmington 475
Ashburn 467
Boardman 386
Woodbridge 350
San Mateo 292
Houston 289
Lawrence 287
Princeton 287
Seattle 280
New York 273
Des Moines 246
Cambridge 213
Ann Arbor 189
Centro 166
San Diego 116
Redmond 95
Porto 79
Beijing 54
Turin 53
Milan 37
Los Angeles 34
Pune 29
Norwalk 27
Pianella 27
Brussels 25
Helsinki 25
London 25
Marche 23
Izmir 18
Auburn Hills 16
Civitanova Marche 15
Washington 12
Prescot 10
Venice 10
Falls Church 9
New Bedfont 8
Rome 8
Ancona 7
Kilburn 7
Catania 6
Jesi 6
Ottawa 6
Chiswick 5
Bristol 4
Corato 4
Frankfurt am Main 4
Hong Kong 4
Montréal 4
Acton 3
Bologna 3
Hanover 3
Nürnberg 3
Phoenix 3
Pistoia 3
San Benedetto Del Tronto 3
Toronto 3
Wandsworth 3
Athens 2
Bangkok 2
Bergamo 2
Bern 2
Caserta 2
Florence 2
Genova 2
Gwangju 2
Madrid 2
Malo 2
Markopoulo Mesogaias 2
Mozzate 2
Parma 2
Rio De Janeiro 2
Rovigo 2
Saint Petersburg 2
Simi Valley 2
Southwark 2
Stockholm 2
Sydney 2
Tappahannock 2
Terlizzi 2
Tolentino 2
Agrigento 1
Agugliano 1
Alghero 1
Andover 1
Augusta 1
Barcelona 1
Bellaria-Igea Marina 1
Berlin 1
Boston 1
Boulder 1
Brescia 1
Bubbiano 1
Bushey 1
Busto Arsizio 1
Castelfranco Emilia 1
Creixell 1
Totale 9.071
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 186
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 128
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 114
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 103
Glial-like differentiation potential of human mature adipocytes 103
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 101
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 98
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 95
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 95
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 94
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 94
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 93
Meningioma-like cerebral relapse of Hodgkin's disease. 93
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 91
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 88
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 88
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 88
Plasticity of human dedifferentiated adipocytes toward endothelial cells 86
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 86
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 85
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 84
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 83
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 83
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 82
Biosafety evidence for human dedifferentiated adipocytes 82
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 81
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 81
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 81
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 80
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 79
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 78
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 78
Molecular and functional characterization of human bone marrow adipocytes 78
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 77
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 77
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 76
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 75
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 75
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 75
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 74
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 74
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 74
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 73
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 72
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 72
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 72
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 71
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 71
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 71
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 71
The value of PCR in the diagnosis and monitoring of early stage of mycosis fungoids treated with Interferon plus PUVA 71
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 71
High remission rate in T-Cell prolymphocytic leukemia with Campath-1H 70
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 70
Risk assessment of patients with Hematologic malignancies who develop fever accompanied by pulmonary infiltrates. A historic cohort study. 70
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 70
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 70
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 70
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 70
Primary B-cell lymphoblastic lymphoma of the testis 69
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 69
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 69
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 69
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 68
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 68
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 68
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 68
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 67
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 67
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 67
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 66
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. 66
Treatment of adult acute lymphoblastic leukemia (ALL): Long-Term Follow-up of the GIMEMA ALL 0288 randomize study 65
Clonal TCR gamma e TCR delta rearrangement in peripheral blood in MF/SS patients 65
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 65
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 65
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 65
Bone marrow adipocytes support haematopoietic stem cell survival 65
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 65
Risk of non-Hodgkin lymphoma in celiac disease 64
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 64
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 64
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 64
Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center 63
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 63
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population 63
Response to fludarabina in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy 62
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 62
[Hodgkin's lymphoma and secondary leukemias]. 62
Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy 62
Toxoplasmosi in bone marrow trasplantation: a report of two cases and systematical review of the literature 61
Signet ring cells are not uncommon in cutaneous B-cell lymphoma and seem not to be associated with a specific clinical behaviour 61
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 61
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 61
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy 60
Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. 60
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 60
TIME TO NEXT TREATMENT ANALYSIS FOR EARLY AND ADVANCED STAGES OF MYCOSIS FUNGOIDES/SEZARY SYNDROME TREATED WITH BEXAROTENE AND PUVA IN COMBINATION 60
Risk of Thromboembolic Events in ET and Early / Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis 59
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 59
Totale 7.572
Categoria #
all - tutte 73.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 4 24
2019/20201.731 73 7 301 4 302 4 292 9 298 12 84 345
2020/20213.544 145 386 545 45 472 193 358 163 427 270 389 151
2021/20222.192 99 621 23 176 16 80 99 171 115 179 159 454
2022/20233.326 344 377 279 260 254 508 1 172 870 19 178 64
2023/20241.668 354 49 102 341 335 369 28 47 5 38 0 0
Totale 15.626